Home » Topics » Regulatory » NMPA

NMPA
RSS

Ganovo approved in China for hepatitis C

June 13, 2018

CFDA clears HG-146 to enter clinical trials for multiple myeloma

May 11, 2018

CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026

April 16, 2018

Chinese authorities approve clinical trials of ZKAB-001

Jan. 30, 2018

China FDA accepts IND for Ascentage's IAP inhibitor

Jan. 9, 2018

CFDA designates lenvatinib for priority review and approval for HCC

Dec. 28, 2017

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Dec. 28, 2017

Ebola vaccine approved in China

Oct. 26, 2017

Fosun Pharma reports Chinese IND application for FCN-437c

July 19, 2017

CStone cleared to begin clinical trials of CS-1001 in China

July 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...